In the homogenized spleens from the vehicle group, approximately 45% CD19+ human leukemia cells were observed, whereas no leukemic cells were detected in spleens from irinotecan-treated mice or the treatment follow-up group (Figure 4F). Here, CD19 is linked to leukemia.